Paper42828342PubMed
Pretreatment Pan-Immune-Inflammation Value and Corrected Prognostic Nutritional Index for 24-Month Recurrence Risk Stratification After Neoadjuvant Chemotherapy and Surgery in Stage III Endometrial Cancer.
Lin R and 3 others. Int J Womens Health, 2026.
Cite this record
ConductScience Library. Pretreatment Pan-Immune-Inflammation Value and Corrected Prognostic Nutritional Index for 24-Month Recurrence Risk Stratification After Neoadjuvant Chemotherapy and Surgery in Stage III Endometrial Cancer. Papers, record 42828342. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42828342
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Pretreatment Pan-Immune-Inflammation Value and Corrected Prognostic Nutritional Index for 24-Month Recurrence Risk Stratification After Neoadjuvant Chemotherapy and Surgery in Stage III Endometrial Cancer.
- Journal
- Int J Womens Health
- Year
- 2026
- Publication types
- Journal Article
- Revised in PubMed
- 2026-10-05
Source PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References53
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33207601 | Metastatic Colonization: Escaping Immune Surveillance. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/33207601 | PubMed |
| 2 | 27558344 | Neutrophils in the tumor microenvironment: trying to heal the wound that cannot heal. | Immunol Rev | 2016 | https://conductscience.org/library/papers/27558344 | PubMed |
| 3 | 39351432 | Pan-immune-inflammation value as a prognostic biomarker for colon cancer and its variation by primary tumor location. | World J Gastroenterol | 2024 | https://conductscience.org/library/papers/39351432 | PubMed |
| 4 | 41227280 | Clinical Utility of Pan-Immune Inflammation Value (PIV) in Predicting Prognosis of Endometrial Cancer. | J Clin Med | 2025 | https://conductscience.org/library/papers/41227280 | PubMed |
| 5 | 38578121 | Prognostic value of peripheral blood neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, pan-immune-inflammation value and systemic immune-inflammation index for the efficacy of immunotherapy in patients with advanced gastric cancer. | Immunotherapy | 2024 | https://conductscience.org/library/papers/38578121 | PubMed |
| 6 | 39563378 | Pan-immune-inflammation value as a novel prognostic biomarker for digestive system cancers: a meta-analysis. | World J Surg Oncol | 2024 | https://conductscience.org/library/papers/39563378 | PubMed |
| 7 | 35681656 | The Association between the Pan-Immune-Inflammation Value and Cancer Prognosis: A Systematic Review and Meta-Analysis. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35681656 | PubMed |
| 8 | 37828259 | Preoperative albumin-to-globulin ratio and prognostic nutritional index predict the prognosis of colorectal cancer: a retrospective study. | Sci Rep | 2023 | https://conductscience.org/library/papers/37828259 | PubMed |
| 9 | 32026332 | Prognostic Nutritional Index and Systemic Immune-Inflammation Index Predict the Prognosis of Patients with HCC. | J Gastrointest Surg | 2021 | https://conductscience.org/library/papers/32026332 | PubMed |
| 10 | 33397713 | ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma. | Int J Gynecol Cancer | 2021 | https://conductscience.org/library/papers/33397713 | PubMed |
| 11 | 38235869 | Prognostic role of the systemic immune-inflammation index and pan-immune inflammation value for outcomes of breast cancer: a systematic review and meta-analysis. | Eur Rev Med Pharmacol Sci | 2024 | https://conductscience.org/library/papers/38235869 | PubMed |
| 12 | 35846958 | Prognostic Nutritional Index in Hepatocellular Carcinoma Patients With Hepatitis B Following US-Guided Percutaneous Microwave Ablation: A Retrospective Study With 1,047 Patients. | Front Surg | 2022 | https://conductscience.org/library/papers/35846958 | PubMed |
| 13 | 41607545 | Dynamic changes in prognostic nutritional index and systemic immune-inflammation index predict survival following debulking surgery in ovarian cancer. | Front Oncol | 2025 | https://conductscience.org/library/papers/41607545 | PubMed |
| 14 | 39609741 | Prognostic nutritional index is an independent risk factor for continuing S-1 adjuvant chemotherapy in patients with pancreatic cancer who received neoadjuvant chemotherapy and surgical resection. | BMC Cancer | 2024 | https://conductscience.org/library/papers/39609741 | PubMed |
| 15 | 35761211 | Clinical implications of neoadjuvant chemotherapy in advanced endometrial cancer: a multi-center retrospective cohort study. | BMC Cancer | 2022 | https://conductscience.org/library/papers/35761211 | PubMed |
| 16 | 33789677 | Platelets, immune cells and the coagulation cascade; friend or foe of the circulating tumour cell? | Mol Cancer | 2021 | https://conductscience.org/library/papers/33789677 | PubMed |
| 17 | 34181998 | Serum albumin levels and inflammation. | Int J Biol Macromol | 2021 | https://conductscience.org/library/papers/34181998 | PubMed |
| 18 | 33175109 | Assessment of Sentinel Lymph Node Biopsy vs Lymphadenectomy for Intermediate- and High-Grade Endometrial Cancer Staging. | JAMA Surg | 2021 | https://conductscience.org/library/papers/33175109 | PubMed |
| 19 | 35925991 | Impact of pre-treatment prognostic nutritional index and the haemoglobin, albumin, lymphocyte and platelet (HALP) score on endometrial cancer survival: A prospective database analysis. | PLoS One | 2022 | https://conductscience.org/library/papers/35925991 | PubMed |
| 20 | 40622006 | Cancer of the corpus uteri: A 2025 update. | Int J Gynaecol Obstet | 2025 | https://conductscience.org/library/papers/40622006 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42828342
GET https://conductscience.org/api/papers/v1/42828342/references?page=2